Structured around development of advanced particle accelerator technology, the Antaya Science & Technology team has played a significant role in developing super conducting accelerators in use today. Founded to commercialize superconducting cyclotron technology developed at the MIT Plasma Fusion Laboratory, AS&T was among the first to apply this innovation to create a compact, affordable, simple-to-operate cyclotrons for use in advanced medical devices and security systems. With large traditional cyclotron site needed, the firm's ISO-X produces “dose-on-demand” delivery of radiopharmaceuticals in hospitals and clinics- available to to patients. Powered by ANTAYA superconducting compact cyclotron - a patent-protected design based on superconducting magnets to significantly reduce its footprint, the ISO-X provides consistent and reliable N-13 Ammonia PET radiopharmaceuticals at the point-of-care to meet the most demanding MPI workload.
